Yüklüyor......
Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma
Secondary malignancies due to alkylating agents or topoisomerase II inhibitors are a concern in patients treated for primary brain tumors of the nervous system. Myelosuppression is the dose-limiting toxic effect of the alkylating agent temozolomide; reversible hematologic toxicity consisting mainly...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams & Wilkins
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3770207/ https://ncbi.nlm.nih.gov/pubmed/23685934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318297eea6 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|